Summary
Updated Aug 30, 2026
Adam Morgan is Director of HERON THERAPEUTICS, INC. /DE/ (HRTX). 2 SEC Form 4 filings on record going back to 2025, most recently on 3 February 2026. Most recent open-market trade: bought $2.65M of HRTX on 12 August 2025. Lifetime open-market purchases: $3.70M.
Recent Transactions
2Every recent SEC Form 4 transaction Adam Morgan has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who have reported open-market trades at the same companies as Adam Morgan. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Rubric Capital Management LP - $5.00M of HRTX open-market activity on record
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Adam Morgan?
Adam Morgan is a corporate insider, tracked as Director of HERON THERAPEUTICS, INC. /DE/ (HRTX). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Adam Morgan last file a Form 4?
The most recent primary Form 4 on record is dated 3 February 2026, one of 2 filings going back to 2025.
Has Adam Morgan been buying or selling stock?
Recorded transactions: 2 open-market purchases ($3.70M) and 0 open-market sales across all tracked filings.
Where can I see all of Adam Morgan's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Adam Morgan and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
